Effect of allergic rhinitis on the use and cost of health services by children with asthma

Yonsei Medical Journal

Volumn 49, Issue 4, 2008, Pages 521-529

  Kang, Hye Young ^a   Park, Choon Seon ^b   Bang, Hye Ryun ^c   Sazonov, Vasilisa ^d   Kim, Chul Joon ^c  

^a Yonsei University   (South Korea)

^b Health Insurance Review Agency   (South Korea)

^c MSD Korean Ltd   (South Korea)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergic rhinitis; Asthma; Cost of illness; Health care cost

Indexed keywords

ACRIVASTINE; ANTIASTHMATIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; EBASTINE; FEXOFENADINE; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MIZOLASTINE; MOMETASONE FUROATE; NEDOCROMIL; THEOPHYLLINE; TRIAMCINOLONE;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CAREGIVER; CHILD; CHILD HEALTH CARE; COMORBIDITY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG COST; EMERGENCY WARD; FEMALE; GENERAL HOSPITAL; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT TRANSPORT; PREVALENCE; RISK ASSESSMENT;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES; HUMANS; HYPERSENSITIVITY; INFANT; MALE; RHINITIS;

EID: 52949103678     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.4.521     Document Type: Article

References (20)

1. Chung F, Barnes N, Allen M, Angus R, Corris P, Knox A, et al. Assessing the burden of respiratory disease in the UK. Respir Med 2002;96:963-75.
2. Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8:161-76.
3. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108 (5 Suppl):S147-334.
4. Schoenwetter WF, Dupclay L Jr, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-sof-life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305-17.
5. Blaiss MS. Cognitive, social and economic costs of allergic rhinitis. Allergy Asthma Proc 2000;21:7-13.
6. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:3-8.
7. Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999;103:54-9.
8. Grupp-Phelan J, Lozano P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma 2001;38:363-73.
9. Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics 2005;115:129-,34.
10. Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander JA, Venditti L. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999;16:1-8.
11. Crown WH, Olufade A, Smith MW, Nathan R. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns. Value Health 2003;6:448-56.
12. Jung HJ. Estimating non-covered medical cost. Health Insurance Forum 2002;1:73-97 (Korean).
13. Yang BM. Developing criteria for estimating standard costs used in economic evaluation studies for medicines (technical report: Korean). Seoul, Korea: Health Insurance Review Agency; 2004. p.149.
14. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Chapter 7. Cost-benefit analysis. In: Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005. p.216.
15. Korea National Statistics Office. Age- and gender-specific participation rate to labor market 2002. Available form: URL: http://www.kosis.kr.
16. Korean Ministry of Labor. Statistics for wage structure. 2002. Available form: URL: http://www.laborstat.molab.go.kr.
17. Korea YWCA. Personal talk with Korea YWCA administrator 2004.
18. Yang BM. Developing criteria for estimating standard costs used in economic evaluation studies for medicines (technical report: Korean). Seoul, Korea: Health Insurance Review Agency; 2004. p.152-3.
19. Garcia-Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: The MOSAIC study. Pediatrics 2005;116:360-9.
20. Kang HY, Kim HJ, Park TK, Jee SH, Nam CM, Park HW. Economic burden of smoking in Korea. Tob Control 2003;12:37-44.